Business30 Aralık 2025Arrowhead Pharma’nın CEO’su Anzalone 3,5 milyon dolarlık hisse sattıSOURCE:Investing Türkiye|BY:Investing.comFailed to fetch content: Request failed with error code 403Share:Read Original Article →